INCLUDE-CKD: INCLUsive Digital carE for Chronic Kidney Disease
ConditionChronic Kidney Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPortsmouth Hospitals NHS Trust
About this trial
This study will provide valuable insights into the demographics of MyRenalCare users, their digital adherence, and the overall impact of the app on health outcomes, healthcare costs, and environmental sustainability.
Eligibility criteria
Qualifiers
Aged 18 years or over.
Under the care of the Wessex Kidney Centre
Registered with, or offered and subsequently enrolled onto, the MyRenalCare platform during the defined retrospective or prospective periods.
Able to understand study information and, where applicable, provide informed consent for use of their data for research purposes.
Disqualifiers
Patients with acute kidney injury without established chronic kidney disease.
Patients with a very limited life expectancy where participation in routine digital monitoring is not appropriate, as judged by the clinical team.
Patients who have previously indicated that they do not wish their routinely collected clinical data to be used for research where such opt-out applies to this study.
Patients who are unable to be identified reliably in the available data sources (for example, inconsistent or missing key identifiers).
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
1,000 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Portsmouth Hospitals NHS Trust
Lead sponsor
Ardia Digital Health Ltd
Collaborator
Source ClinicalTrials.gov